Amyloid Fibrils
Type IV Collagen of Basal Lamina
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Ute Hegenbart1, Fabian Aus dem Siepen2, Stefan Schönland3
1Amyloidose-Zentrum, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland. ute.hegenbart@med.uni-heidelberg.de.
Light chain amyloidosis (AL) is a rare plasma cell disorder affecting organs, especially the heart. Early diagnosis and chemotherapy to reduce light chains are crucial for effective treatment and survival.
Area of Science: